The Influence of the Dietary Inflammatory Index (DII) on Cancer Risk
Principal Investigator
Name
James Hebert
Degrees
ScD
Institution
Arnold School of Public Health University of South Carolina
Position Title
Distinguished Professor, Director of South Carolina Statewide Cancer Prevention & Control Program
Email
jhebert@sc.edu
About this CDAS Project
Study
PLCO
(Learn more about this study)
Project ID
PLCO-76
Initial CDAS Request Approval
Apr 11, 2014
Title
The Influence of the Dietary Inflammatory Index (DII) on Cancer Risk
Summary
An estimated 1,665,540 new cancer cases and 585,720 cancer deaths are projected to occur in the United States in 2014. Both experimental and observational studies provide evidence that chronic inflammation plays a crucial role in carcinogenesis. Evidence also shows that diet modulates inflammation, and significantly predicts concentrations of inflammatory biomarkers such as high-sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-6) and tumor necrosis factor alpha receptor 2. Given the evidence that dietary factors can influence inflammatory processes, and the idea that no nutrient is consumed alone but in conjunction with other nutrients and non-nutrient components of food, we previously developed and validated a dietary inflammatory index (DII) to assess the overall quality of diet with regard to its inflammation potential. Briefly, an extensive literature search was performed to obtain peer-reviewed journal articles that examined the association between six inflammatory biomarkers (IL-1, IL-4, IL-6, IL-10, TNFα, and CRP) and 45 specific foods and nutrients (components of the DII). Scores were derived and standardized to a representative global diet database constructed based on 11 datasets from diverse populations in different parts of the world. Overall DII scores for each individual represent the sum of each of the DII components in relation to the comparison database. The DII score characterizes an individual’s diet on a continuum from maximally anti-inflammatory to maximally pro-inflammatory, with a higher DII score indicating a more pro-inflammatory diet and a lower DII score indicating a more anti-inflammatory diet.
Previously we have conducted a number of DII construct validation studies using data from the Women’s Health Initiative (WHI) and Buffalo Cardio-Metabolic Occupational Police Stress (BCOPS) study and found that the DII significantly predicted concentrations of serum hs-CRP, IL-6, TNFα, as well as the glucose intolerance component of the metabolic syndrome. In other studies (e.g., WHI), the DII has been shown also to significantly predict risk of colorectal cancer. The WHI is a large cohort study comprised entirely of older women, while the BCOPS design was cross-sectional.
Given these previous studies, our current objective is to evaluate the association of the DII with risk of total cancer and site-specific cancers in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO). The PLCO is a well characterized and diverse study population with large number of cancer cases that would provide ample power to conduct subgroup analysis by gender and race.
Aims
1) To assess the inflammatory potential of usual diets of PLCO participants and compare with NHANES levels in a descriptive study
2) To evaluate the association of the inflammatory potential of diet and risk of total cancer
3) To evaluate the association of the inflammatory potential of diet and risk of site-specific cancers including colorectal, lung, prostate, breast, liver, pancreatic, and ovarian cancers
Collaborators
Azza Shoaibi
Arnold School of Public Health, University of South Carolina/ Cancer Prevention and Control Program
Nitin Shivappa
Arnold School of Public Health, University of South Carolina/Cancer Prevention and Control Program
Fred Tabung
Arnold School of Public Health, University of South Carolina/Cancer Prevention and Control Program
Michael Wirth
Arnold School of Public Health, University of South Carolina/Cancer Prevention and Control Program
Related Publications
-
Dietary inflammatory index and renal cancer risk: a prospective study.
Wu J, Yu C, Shivappa N, Hébert JR, Xu X
Food Funct. 2023 Oct 16; Volume 14 (Issue 20): Pages 9287-9294 PUBMED -
Dietary Inflammatory Index and Mortality from All Causes, Cardiovascular Disease, and Cancer: A Prospective Study.
Liang Z, Feng Y, Shivappa N, Hebert JR, Xu X
Cancers (Basel). 2022 Sep 22; Volume 14 (Issue 19) PUBMED -
Long-term anti-inflammatory diet in relation to improved breast cancer prognosis: a prospective cohort study.
Wang K, Sun JZ, Wu QX, Li ZY, Li DX, Xiong YF, Zhong GC, Shi Y, Li Q, Zheng J, Shivappa N, Hébert JR, Foukakis T, Zhang X, Li HY, Xiang TX, Ren GS
NPJ Breast Cancer. 2020; Volume 6: Pages 36 PUBMED -
Dietary inflammatory index and bladder cancer risk: a prospective study.
Luo J, Shivappa N, Hébert JR, Xu X
Eur J Clin Nutr. 2020 Mar 19 PUBMED -
Inflammatory potential of diet and risk of pancreatic cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.
Zheng J, Merchant AT, Wirth MD, Zhang J, Antwi SO, Shoaibi A, Shivappa N, Stolzenberg-Solomon RZ, Hebert JR, Steck SE
Int. J. Cancer. 2018 Jan PUBMED -
The association between Dietary Inflammatory Index scores and the prevalence of colorectal adenoma.
Haslam A, Wagner Robb S, Hébert JR, Huang H, Wirth MD, Shivappa N, Ebell MH
Public Health Nutr. 2017 Jun; Volume 20 (Issue 9): Pages 1609-1616 PUBMED